Australia is carefully awaiting the arrival of retatrutide, a novel dual GIP and GLP-1 receptor agonist that's generating significant buzz in the global weight management landscape. Developed by Novo Nordisk, this https://alyssavyfc869653.ktwiki.com/2476582/novo_nordisk_s_retatrutide_australia_a_promising_solution_for_losing_weight